FDA Inspection 1101374 — Carl J. Gessler, Jr., M.D.
The FDA completed an inspection of Carl J. Gessler, Jr., M.D. on August 23, 2019 in Huntsville, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Huntsville, AL (United States)
Additional Details
Clinical Investigator (CI)